PATENT CLAIM ANALYSIS

Application Number: 16107087
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "064000"]

Abstract:
Compounds according to Formula I are potent inhibitors of Arginase I and II activity: where R 1 , R 2 , R 3 , R 4 , D, W, X, Y, and Z are defined in the specification. The invention also provides pharmaceutical compositions of the compounds and methods of their use in treating or preventing a disease or a condition associated with arginase activity.

Claim (Index 42):
The compound according to  claim 41 , wherein\n R\u2032\u2033 is selected from H, \u2014OH, \u2014S(O)R d , \u2014S(O) 2 R d , (C 1 -C 8 )alkyl, (C 3 -C 14 )aryl, \u2014NH 2 , \u2014NH(C 1 -C 6 )alkyl, \u2014N[(C 1 -C 6 )alkyl] 2 , \u2014C(O)(C 1 -C 6 )alkyl, \u2014C(O)C 3 -C 14 )aryl, \u2014C(O)O(C 1 -C 6 )alkyl, \u2014C(O)O(C 3 -C 14 )aryl, (C 3 -C 6 )cycloalkyl, (C 3 -C 14 )heterocycloalkyl, \u2014C(O)(C 3 -C 14 )heterocycloalkyl, (C 3 -C 14 )heteroaryl, (C 3 -C 14 )aryl-(C 1 -C 6 )alkylene-, (C 3 -C 6 )cycloalkyl-(C 1 -C 6 )alkylene-, (C 3 -C 14 )heteroaryl-(C 1 -C 6 )alkylene- and (C 3 -C 14 )heterocycle-(C 1 -C 6 )alkylene-, or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 96.0
- Lexical Diversity: 1.44
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15207902', '13276806', '14614115', '14471244', '15972996']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7892731364290958
- 35 USC 102 Novelty (BERT): 0.5643610897704454
- Combined Prediction Score: 0.7667819317632307
- Mean Citation Score: 401.323864
- Max Citation Score: 423.62912
- Similarity Product: 386.5460784384918

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test